Fortress-founded Caelum Biosciences to receive $60 million in a strategic equity investment and option fee
Alexion has option to acquire Caelum Biosciences based on Phase 2 data
finance.yahoo.com/news/fortress-biotech-announces-cael-101-113000172.html?.tsrc=rss
Alexion has option to acquire Caelum Biosciences based on Phase 2 data
finance.yahoo.com/news/fortress-biotech-announces-cael-101-113000172.html?.tsrc=rss
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.